Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies

作者: Victor J. Dzau , Ruediger C. Braun-Dullaeus , Daniel G. Sedding

DOI: 10.1038/NM1102-1249

关键词:

摘要: In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well formation of fibrous cap that provides stability plaque. The VSMC can undergo a proliferative response underlies development in-stent restenosis, bypass graft occlusion transplant vasculopathy. Although benefit/risk therapeutic inhibition proliferation in atherosclerosis is unclear, experimental human evidence strongly suggests potential antiproliferative therapy for failure other disorders.

参考文章(85)
Sherr Cj, Mammalian G1 cyclins and cell cycle progression. Proceedings of the Association of American Physicians. ,vol. 107, pp. 181- ,(1995)
L Détivaud, C Doerig, L Meijer, N Gray, ATP-site directed inhibitors of cyclin-dependent kinases. Current Medicinal Chemistry. ,vol. 6, pp. 859- 875 ,(1999)
A M Gown, R Ross, H C Boyd, C Fligner, S Katsuda, Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. American Journal of Pathology. ,vol. 140, pp. 907- 914 ,(1992)
Robert Kleemann, Angelika Hausser, Georg Geiger, Ralf Mischke, Anke Burger-Kentischer, Oliver Flieger, Franz-Josef Johannes, Thierry Roger, Thierry Calandra, Aphrodite Kapurniotu, Matthias Grell, Doris Finkelmeier, Herwig Brunner, Jürgen Bernhagen, Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 Nature. ,vol. 408, pp. 211- 216 ,(2000) , 10.1038/35041591
Michael J.B Kutryk, David P Foley, Marcel van den Brand, Jaap N Hamburger, Willem J van der Giessen, Pim J deFeyter, Nico Bruining, Manel Sabate, Patrick W Serruys, Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial Journal of the American College of Cardiology. ,vol. 39, pp. 281- 287 ,(2002) , 10.1016/S0735-1097(01)01741-7
Edith Giasson, Sylvain Meloche, Role of p70 S6 Protein Kinase in Angiotensin II-induced Protein Synthesis in Vascular Smooth Muscle Cells Journal of Biological Chemistry. ,vol. 270, pp. 5225- 5231 ,(1995) , 10.1074/JBC.270.10.5225
M J Mann, G H Gibbons, P S Tsao, H E von der Leyen, J P Cooke, R Buitrago, R Kernoff, V J Dzau, Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts. Journal of Clinical Investigation. ,vol. 99, pp. 1295- 1301 ,(1997) , 10.1172/JCI119288
Akio Ishida, Toshiyuki Sasaguri, Chiya Kosaka, Hiroshi Nojima, Jun Ogata, Induction of the Cyclin-dependent Kinase Inhibitor p21Sdi1/Cip1/Waf1 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells Journal of Biological Chemistry. ,vol. 272, pp. 10050- 10057 ,(1997) , 10.1074/JBC.272.15.10050
Xiao-Feng Zheng, David Fiorentino, Jie Chen, Gerald R. Crabtree, Stuart L. Schreiber, TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin Cell. ,vol. 82, pp. 121- 130 ,(1995) , 10.1016/0092-8674(95)90058-6